We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA’s EudraVigilance Report Shows Uptick in Patient-Reported Adverse Events
EMA’s EudraVigilance Report Shows Uptick in Patient-Reported Adverse Events
The European Medicines Agency (EMA) says the EU’s EudraVigilance database received more than 1 million post-marketing expedited adverse-drug-reaction (ADR) reports in 2013.